[1]
Humbert, M.; Kovacs, G.; Hoeper, M.M.; Badagliacca, R.; Berger, R.M.F. Brida Meta al. ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Heart J., 2022, 43, 3618-3731. [PMID: 36017548].
[2]
Simonneau, G.; Montani, D.; Celermajer, D.S.; Denton, C.P.; Gatzoulis, M.A.; Krowka, M.; Williams, P.G.; Souza, R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur. Respir. J., 2019, 531801913 [PMID: 30545968].
[3]
Maron, B.A.; Brittain, E.L.; Hess, E.; Waldo, S.W.; Barón, A.E.; Huang, S. Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study. Lancet Respir. Med., 2020, 8, 873-884. [PMID: 32730752].
[4]
Hassoun, P.M. Pulmonary Arterial Hypertension. N. Engl. J. Med., 2021, 385, 2361-2376. [PMID: 34910865].
[5]
D’Alonzo, G.E.; Barst, R.J.; Ayres, S.M.; Bergofsky, E.H.; Brundage, B.H.; Detre, K.M.; Fishman, A.P.; Goldring, R.M.; Groves, B.M.; Kernis, J.T. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann. Intern. Med., 1991, 115, 343-349. [PMID: 1863023].
[6]
Hendriks, P.M.; Staal, D.P.; van de Groep, L.D.; van den Toorn, L.M.; Chandoesing, P.P.; Kauling, R.M.; Mager, H.J.; van den Bosch, A.E.; Post, M.C.; Boomars, K.A. The evolution of survival of pulmonary arterial hypertension over 15 years. Pulm. Circ., 2022, 12e12137 [PMID: 36268054].
[7]
Savarese, G.; Becher, P.M.; Lund, L.H.; Seferovic, P.; Rosano, G.M.C.; Coats, A.J.S. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc. Res., 2023, 118, 3272-3287. [PMID: 35150240].
[8]
Rosenkranz, S.; Gibbs, J.S.; Wachter, R.; De Marco, T.; Vonk-Noordegraaf, A.; Vachiéry, J.L. Left ventricular heart failure and pulmonary hypertension. Eur. Heart J., 2016, 37, 942-954. [PMID: 26508169].
[9]
Tichelbäcker, T.; Dumitrescu, D.; Gerhardt, F.; Stern, D.; Wissmüller, M.; Adam, M.; Schmidt, T.; Frerker, C.; Pfister, R.; Halbach, M.; Baldus, S.; Rosenkranz, S. Pulmonary hypertension and valvular heart disease. Herz, 2019, 44, 491-501. [PMID: 31312873].
[10]
Nathan, S.D.; Barbera, J.A.; Gaine, S.P.; Harari, S.; Martinez, F.J.; Olschewski, H.; Olsson, K.M.; Peacock, A.J.; Pepke-Zaba, J.; Provencher, S.; Weissmann, N.; Seeger, W. Pulmonary hypertension in chronic lung disease and hypoxia. Eur. Respir. J., 2019, 531801914 [PMID: 30545980].
[11]
Waxman, A.; Restrepo-Jaramillo, R.; Thenappan, T.; Ravichandran, A.; Engel, P.; Bajwa, A.; Allen, R.; Feldman, J.; Argula, R.; Smith, P.; Rollins, K.; Deng, C.; Peterson, L.; Bell, H.; Tapson, V.; Nathan, S.D. Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease. N. Engl. J. Med., 2021, 384, 325-334. [PMID: 33440084].
Related Journals
